Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biomind Labs Inc N.BMND

Alternate Symbol(s):  BMNDF

Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.


NEO:BMND - Post by User

Bullboard Posts
Post by DTM5on Dec 03, 2009 9:50am
298 Views
Post# 16549395

RIP OFF!

RIP OFF!$1.20 Cash - Are they kidding???
A 20% premium to a stock whose price keeps going up each week??  
This is the most blatant and predatory takeover solicitation I have every seen.  CA Bancorp has a book value of approx 2.50 per share in companies they can sell off / wind out into the market EASILY over a year or two.
Next year CA will be earnings positive and they've already stated they'll be selling some of their private companies and meaningful gains.  
Maxam is trying to bag this one before the price gets too high and realized the value for themselves.  This offer should be resoundingly REJECTED by all shareholders.  Its a rip off and insulting.   
Bullboard Posts